RECURRENT BLADDER UROTHELIAL CARCINOMA

Clinical trials for RECURRENT BLADDER UROTHELIAL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT BLADDER UROTHELIAL CARCINOMA trials appear

Sign up with your email to follow new studies for RECURRENT BLADDER UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New combo shows promise for Tough-to-Treat bladder cancer

Disease control Ongoing

This study tests whether adding the chemotherapy drug eribulin to the immunotherapy atezolizumab works better than atezolizumab alone for people with advanced urothelial cancer (a type of bladder cancer) that has spread or come back. The study includes 72 adults who cannot take t…

Matched conditions: RECURRENT BLADDER UROTHELIAL CARCINOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated May 01, 2026 16:00 UTC

RECURRENT BLADDER UROTHELIAL CARCINOMA

Get alerted when new RECURRENT BLADDER UROTHELIAL CARCINOMA trials appear

New combo shows promise for Tough-to-Treat bladder cancer